Lake Street Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-6,502
Closed -$799K – 311
2023
Q3
$799K Buy
+6,502
New +$827K 0.14% 142
2022
Q2
– Sell
-1,583
Closed -$206K – 315
2022
Q1
$206K Sell
1,583
-5,500
-78% -$716K 0.04% 298
2021
Q4
$1.08M Buy
7,083
+1,187
+20% +$184K 0.19% 121
2021
Q3
$953K Sell
5,896
-13
-0.2% -$2.19K 0.23% 104
2021
Q2
$976K Sell
5,909
-384
-6% -$59.1K 0.25% 99
2021
Q1
$947K Buy
6,293
+1,897
+43% +$301K 0.26% 100
2020
Q4
$666K Buy
4,396
+1,269
+41% +$181K 0.19% 111
2020
Q3
$423K Sell
3,127
-165
-5% -$22.4K 0.14% 122
2020
Q2
$449K Buy
3,292
+566
+21% +$72.2K 0.17% 110
2020
Q1
$294K Buy
+2,726
New +$314K 0.13% 119

Other funds holding IBB

Lake Street Private Wealth's IBB Position: Q4 2023 in Review

Lake Street Private Wealth sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 6,502 shares — an estimated $799K sold.

Lake Street Private Wealth first reported a position in IBB in Q1 2020 and held it in 10 quarters. The position peaked at $1.08M in Q4 2021. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • Lake Street Private Wealth reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • Lake Street Private Wealth sold 6,502 iShares Biotechnology ETF shares in Q4 2023, an estimated $799K.
  • Lake Street Private Wealth first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 10 quarters.
  • Lake Street Private Wealth's iShares Biotechnology ETF position peaked at $1.08M in Q4 2021.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on Lake Street Private Wealth's 13F filing for Q4 2023, filed 10 Jan 2024.